Loading…
Bharat Immunological & Biological Corporation (BSE 524663)₹8.75+0.57%Pharmaceuticals
At the end of the Mar 2024 quarter, Bharat Immunological & Biological Corporation's shareholders were: promoters 59.20%, public 40.80%. Promoter holding is unchanged on the quarter. It had 35,303 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% | 59.20% |
| Public | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% | 40.80% |
| Number of shareholders | 38,184 | 36,788 | 36,858 | 36,313 | 35,685 | 35,432 | 36,232 | 35,540 | 34,808 | 34,191 | 34,900 | 35,303 |
| Holder | Category | Mar 2024 | Change (pp) |
|---|---|---|---|
| President Of India | Promoter | 59.21% | 0.00 |
Promoters held 59.20% of Bharat Immunological & Biological Corporation at the end of the Mar 2024 quarter, the same as a year earlier.
Bharat Immunological & Biological Corporation had 35,303 shareholders at the end of the Mar 2024 quarter, against 35,540 a year earlier.